Vitamin B6 may provide protection against cognitive decline in the elderly, study suggests
The results of the recent, comprehensive Age-Related Disease Study 2 (AREDS2) failed to support the prevailing view that marine omega-3 fatty acids could have a protective role in preventing the onset and progression of age-related macular degeneration (ARMD). Professor Eric Souied, Head of the Department of Ophthalmology at both the Hôpital Intercommunal de Créteil and the Hôpital Henri Mondor in France, has carefully reviewed the study and found that the null results could be due to methodological differences between this and other recent studies. He thinks that the evidence from laboratory and other clinical studies still provides hope that omega-3 fatty acids could provide benefits in relation to ARMD.
Professor Mary Ward of Ulster University was part of a recent trial in which it was shown that elderly Irish adults (60 years or more) who were deficient in 25-hydroxyvitamin D (<25 nmol/L) were most likely to have the highest levels of inflammatory cytokines when compared to those who were replete (>75 nmol/L). Raised levels of these inflammatory cytokines are associated with increased risk of cardiovascular disease and a range of other chronic diseases.
In his recent work, Francesco Visioli – Professor of Human Nutrition in the Department of Molecular Medicine at the University of Padova in Italy – has investigated the biological and pharmacological properties of olive oil phenolics, including hydroxytyrosol, and their ability to reduce the risk of atherosclerosis and cardiovascular disease.
A new analysis of data by Professor Maria Makrides’ group at Adelaide University in Australia has shown that in-patient hospital costs could decrease by 92 Australian Dollars (AUD) on average per pregnancy (single) when a daily supplement of 800 mg docosahexaenoic acid (DHA) was consumed during pregnancy, due mainly to the reduced risk of giving premature birth.